메뉴 건너뛰기




Volumn 16, Issue 1, 2015, Pages

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

(23)  Ng, Charlotte K Y a   Martelotto, Luciano G a   Gauthier, Arnaud b   Wen, Huei Chi a   Piscuoglio, Salvatore a   Lim, Raymond S a   Cowell, Catherine F a   Wilkerson, Paul M c   Wai, Patty c   Rodrigues, Daniel N c   Arnould, Laurent d   Geyer, Felipe C e   Bromberg, Silvio E e   Lacroix Triki, Magali f   Penault Llorca, Frederique g   Giard, Sylvia h   Sastre Garau, Xavier b   Natrajan, Rachael c   Norton, Larry a   Cottu, Paul H b   more..


Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BRF2 GENE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COPY NUMBER VARIATION; DSN1 GENE; GENE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; HUMAN; IN VITRO STUDY; MUTATIONAL ANALYSIS; ONCOGENE NEU; SEQUENCE ANALYSIS; SOMATIC MUTATION; BREAST TUMOR; FEMALE; GENE AMPLIFICATION; GENETICS; MCF-7 CELL LINE; METABOLISM; MUTATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

EID: 84939165961     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/s13059-015-0657-6     Document Type: Article
Times cited : (116)

References (65)
  • 1
    • 84890254448 scopus 로고    scopus 로고
    • Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
    • Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997-4013.
    • (2013) J Clin Oncol. , vol.31 , pp. 3997-4013
    • Wolff, A.C.1    Hammond, M.E.2    Hicks, D.G.3    Dowsett, M.4    McShane, L.M.5    Allison, K.H.6
  • 4
    • 37049183697 scopus 로고
    • Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
    • Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177-82.
    • (1987) Science. , vol.235 , pp. 177-182
    • Slamon, D.J.1    Clark, G.M.2    Wong, S.G.3    Levin, W.J.4    Ullrich, A.5    McGuire, W.L.6
  • 6
    • 84890280905 scopus 로고    scopus 로고
    • Biomarkers of drugs targeting HER-family signalling in cancer
    • Montemurro F, Scaltriti M. Biomarkers of drugs targeting HER-family signalling in cancer. J Pathol. 2014;232:219-29.
    • (2014) J Pathol. , vol.232 , pp. 219-229
    • Montemurro, F.1    Scaltriti, M.2
  • 8
    • 84878083237 scopus 로고    scopus 로고
    • Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations
    • Ross JS, Wang K, Sheehan CE, Boguniewicz AB, Otto G, Downing SR, et al. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations. Clin Cancer Res. 2013;19:2668-76.
    • (2013) Clin Cancer Res. , vol.19 , pp. 2668-2676
    • Ross, J.S.1    Wang, K.2    Sheehan, C.E.3    Boguniewicz, A.B.4    Otto, G.5    Downing, S.R.6
  • 9
    • 84862526929 scopus 로고    scopus 로고
    • The clonal and mutational evolution spectrum of primary triple-negative breast cancers
    • Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486:395-9.
    • (2012) Nature. , vol.486 , pp. 395-399
    • Shah, S.P.1    Roth, A.2    Goya, R.3    Oloumi, A.4    Ha, G.5    Zhao, Y.6
  • 10
    • 84877028141 scopus 로고    scopus 로고
    • Comprehensive molecular portraits of human breast tumours
    • The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61-70.
    • (2012) Nature , vol.490 , pp. 61-70
  • 11
    • 84888391516 scopus 로고    scopus 로고
    • ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
    • Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013;45:1439-45.
    • (2013) Nat Genet. , vol.45 , pp. 1439-1445
    • Toy, W.1    Shen, Y.2    Won, H.3    Green, B.4    Sakr, R.A.5    Will, M.6
  • 12
    • 84888381937 scopus 로고    scopus 로고
    • Activating ESR1 mutations in hormone-resistant metastatic breast cancer
    • Robinson DR, Wu YM, Vats P, Su F, Lonigro RJ, Cao X, et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet. 2013;45:1446-51.
    • (2013) Nat Genet. , vol.45 , pp. 1446-1451
    • Robinson, D.R.1    Wu, Y.M.2    Vats, P.3    Su, F.4    Lonigro, R.J.5    Cao, X.6
  • 13
    • 84884559238 scopus 로고    scopus 로고
    • Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts
    • Li S, Shen D, Shao J, Crowder R, Liu W, Prat A, et al. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep. 2013;4:1116-30.
    • (2013) Cell Rep. , vol.4 , pp. 1116-1130
    • Li, S.1    Shen, D.2    Shao, J.3    Crowder, R.4    Liu, W.5    Prat, A.6
  • 15
    • 77949809850 scopus 로고    scopus 로고
    • Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
    • Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, et al. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol. 2010;220:562-73.
    • (2010) J Pathol. , vol.220 , pp. 562-573
    • Geyer, F.C.1    Weigelt, B.2    Natrajan, R.3    Lambros, M.B.4    Biase, D.5    Vatcheva, R.6
  • 18
    • 84906238686 scopus 로고    scopus 로고
    • Clonal evolution in breast cancer revealed by single nucleus genome sequencing
    • Wang Y, Waters J, Leung ML, Unruh A, Roh W, Shi X, et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature. 2014;512:155-60.
    • (2014) Nature. , vol.512 , pp. 155-160
    • Wang, Y.1    Waters, J.2    Leung, M.L.3    Unruh, A.4    Roh, W.5    Shi, X.6
  • 19
    • 84867121875 scopus 로고    scopus 로고
    • Intratumor heterogeneity: evolution through space and time
    • Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012;72:4875-82.
    • (2012) Cancer Res. , vol.72 , pp. 4875-4882
    • Swanton, C.1
  • 20
    • 40549092394 scopus 로고    scopus 로고
    • Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer
    • Cottu PH, Asselah J, Lae M, Pierga JY, Dieras V, Mignot L, et al. Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer. Ann Oncol. 2008;19:595-7.
    • (2008) Ann Oncol. , vol.19 , pp. 595-597
    • Cottu, P.H.1    Asselah, J.2    Lae, M.3    Pierga, J.Y.4    Dieras, V.5    Mignot, L.6
  • 21
    • 33847165329 scopus 로고    scopus 로고
    • Intratumoral heterogeneity of HER2/neu in breast cancer-a rare event
    • Hanna W, Nofech-Mozes S, Kahn HJ. Intratumoral heterogeneity of HER2/neu in breast cancer-a rare event. Breast J. 2007;13:122-9.
    • (2007) Breast J. , vol.13 , pp. 122-129
    • Hanna, W.1    Nofech-Mozes, S.2    Kahn, H.J.3
  • 22
    • 84863470138 scopus 로고    scopus 로고
    • Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
    • Seol H, Lee HJ, Choi Y, Lee HE, Kim YJ, Kim JH, et al. Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance. Mod Pathol. 2012;25:938-48.
    • (2012) Mod Pathol. , vol.25 , pp. 938-948
    • Seol, H.1    Lee, H.J.2    Choi, Y.3    Lee, H.E.4    Kim, Y.J.5    Kim, J.H.6
  • 23
    • 77951938263 scopus 로고    scopus 로고
    • Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer
    • Wu JM, Halushka MK, Argani P. Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer. Hum Pathol. 2010;41:914-7.
    • (2010) Hum Pathol. , vol.41 , pp. 914-917
    • Wu, J.M.1    Halushka, M.K.2    Argani, P.3
  • 24
    • 84891747133 scopus 로고    scopus 로고
    • HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
    • Hanna WM, Ruschoff J, Bilous M, Coudry RA, Dowsett M, Osamura RY, et al. HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity. Mod Pathol. 2014;27:4-18.
    • (2014) Mod Pathol. , vol.27 , pp. 4-18
    • Hanna, W.M.1    Ruschoff, J.2    Bilous, M.3    Coudry, R.A.4    Dowsett, M.5    Osamura, R.Y.6
  • 25
    • 77954526150 scopus 로고    scopus 로고
    • American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    • Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784-95.
    • (2010) J Clin Oncol. , vol.28 , pp. 2784-2795
    • Hammond, M.E.1    Hayes, D.F.2    Dowsett, M.3    Allred, D.C.4    Hagerty, K.L.5    Badve, S.6
  • 26
    • 84861527388 scopus 로고    scopus 로고
    • The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
    • Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346-52.
    • (2012) Nature. , vol.486 , pp. 346-352
    • Curtis, C.1    Shah, S.P.2    Chin, S.F.3    Turashvili, G.4    Rueda, O.M.5    Dunning, M.J.6
  • 29
    • 68849084073 scopus 로고    scopus 로고
    • RCP is a human breast cancer-promoting gene with Ras-activating function
    • Zhang J, Liu X, Datta A, Govindarajan K, Tam WL, Han J, et al. RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest. 2009;119:2171-83.
    • (2009) J Clin Invest. , vol.119 , pp. 2171-2183
    • Zhang, J.1    Liu, X.2    Datta, A.3    Govindarajan, K.4    Tam, W.L.5    Han, J.6
  • 31
    • 84883325272 scopus 로고    scopus 로고
    • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
    • Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206-23.
    • (2013) Ann Oncol. , vol.24 , pp. 2206-2223
    • Goldhirsch, A.1    Winer, E.P.2    Coates, A.S.3    Gelber, R.D.4    Piccart-Gebhart, M.5    Thurlimann, B.6
  • 32
    • 2942738959 scopus 로고    scopus 로고
    • Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity
    • Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R, et al. Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol. 2004;24:5835-43.
    • (2004) Mol Cell Biol. , vol.24 , pp. 5835-5843
    • Danovi, D.1    Meulmeester, E.2    Pasini, D.3    Migliorini, D.4    Capra, M.5    Frenk, R.6
  • 33
    • 79952093026 scopus 로고    scopus 로고
    • ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
    • Holland DG, Burleigh A, Git A, Goldgraben MA, Perez-Mancera PA, Chin SF, et al. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol Med. 2011;3:167-80.
    • (2011) EMBO Mol Med. , vol.3 , pp. 167-180
    • Holland, D.G.1    Burleigh, A.2    Git, A.3    Goldgraben, M.A.4    Perez-Mancera, P.A.5    Chin, S.F.6
  • 34
  • 35
    • 52049083886 scopus 로고    scopus 로고
    • Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer
    • Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, et al. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res. 2008;68:7165-75.
    • (2008) Cancer Res. , vol.68 , pp. 7165-7175
    • Bernard-Pierrot, I.1    Gruel, N.2    Stransky, N.3    Vincent-Salomon, A.4    Reyal, F.5    Raynal, V.6
  • 36
    • 33846209170 scopus 로고    scopus 로고
    • Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer
    • Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 2006;66:11632-43.
    • (2006) Cancer Res. , vol.66 , pp. 11632-11643
    • Yang, Z.Q.1    Streicher, K.L.2    Ray, M.E.3    Abrams, J.4    Ethier, S.P.5
  • 37
    • 34248340402 scopus 로고    scopus 로고
    • eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration
    • Amiri A, Noei F, Jeganathan S, Kulkarni G, Pinke DE, Lee JM. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene. 2007;26:3027-40.
    • (2007) Oncogene. , vol.26 , pp. 3027-3040
    • Amiri, A.1    Noei, F.2    Jeganathan, S.3    Kulkarni, G.4    Pinke, D.E.5    Lee, J.M.6
  • 38
    • 56649108007 scopus 로고    scopus 로고
    • CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer
    • Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerod A, et al. CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Mol Oncol. 2008;2:327-39.
    • (2008) Mol Oncol. , vol.2 , pp. 327-339
    • Bergamaschi, A.1    Kim, Y.H.2    Kwei, K.A.3    Choi, Y.4    Bocanegra, M.5    Langerod, A.6
  • 39
    • 80051923932 scopus 로고    scopus 로고
    • Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
    • Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476:346-50.
    • (2011) Nature. , vol.476 , pp. 346-350
    • Possemato, R.1    Marks, K.M.2    Shaul, Y.D.3    Pacold, M.E.4    Kim, D.5    Birsoy, K.6
  • 41
    • 78449268847 scopus 로고    scopus 로고
    • Transforming properties of 8p11-12 amplified genes in human breast cancer
    • Yang ZQ, Liu G, Bollig-Fischer A, Giroux CN, Ethier SP. Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res. 2010;70:8487-97.
    • (2010) Cancer Res. , vol.70 , pp. 8487-8497
    • Yang, Z.Q.1    Liu, G.2    Bollig-Fischer, A.3    Giroux, C.N.4    Ethier, S.P.5
  • 42
    • 77955034636 scopus 로고    scopus 로고
    • Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma
    • Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, Malloff CA, et al. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. PLoS Med. 2010;7, e1000315.
    • (2010) PLoS Med. , vol.7
    • Lockwood, W.W.1    Chari, R.2    Coe, B.P.3    Thu, K.L.4    Garnis, C.5    Malloff, C.A.6
  • 43
  • 44
    • 25444443688 scopus 로고    scopus 로고
    • Modelling glandular epithelial cancers in three-dimensional cultures
    • Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005;5:675-88.
    • (2005) Nat Rev Cancer. , vol.5 , pp. 675-688
    • Debnath, J.1    Brugge, J.S.2
  • 45
    • 84908867220 scopus 로고    scopus 로고
    • Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
    • Weinreb I, Piscuoglio S, Martelotto LG, Waggott D, Ng CK, Perez-Ordonez B, et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat Genet. 2014;46:1166-9.
    • (2014) Nat Genet. , vol.46 , pp. 1166-1169
    • Weinreb, I.1    Piscuoglio, S.2    Martelotto, L.G.3    Waggott, D.4    Ng, C.K.5    Perez-Ordonez, B.6
  • 46
    • 75149170979 scopus 로고    scopus 로고
    • Fibroblast growth factor signalling: from development to cancer
    • Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer. 2010;10:116-29.
    • (2010) Nat Rev Cancer. , vol.10 , pp. 116-129
    • Turner, N.1    Grose, R.2
  • 48
    • 84895929400 scopus 로고    scopus 로고
    • Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast
    • Natrajan R, Wilkerson PM, Marchio C, Piscuoglio S, Ng CK, Wai P, et al. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol. 2014;232:553-65.
    • (2014) J Pathol. , vol.232 , pp. 553-565
    • Natrajan, R.1    Wilkerson, P.M.2    Marchio, C.3    Piscuoglio, S.4    Ng, C.K.5    Wai, P.6
  • 50
    • 84863717944 scopus 로고    scopus 로고
    • Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
    • Masciari S, Dillon DA, Rath M, Robson M, Weitzel JN, Balmana J, et al. Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat. 2012;133:1125-30.
    • (2012) Breast Cancer Res Treat. , vol.133 , pp. 1125-1130
    • Masciari, S.1    Dillon, D.A.2    Rath, M.3    Robson, M.4    Weitzel, J.N.5    Balmana, J.6
  • 51
    • 34547854801 scopus 로고    scopus 로고
    • The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
    • Moasser MM. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene. 2007;26:6469-87.
    • (2007) Oncogene. , vol.26 , pp. 6469-6487
    • Moasser, M.M.1
  • 52
    • 84890282746 scopus 로고    scopus 로고
    • Epistatic interactions and drug response
    • Weigelt B, Reis-Filho JS. Epistatic interactions and drug response. J Pathol. 2014;232:255-63.
    • (2014) J Pathol. , vol.232 , pp. 255-263
    • Weigelt, B.1    Reis-Filho, J.S.2
  • 53
    • 26944465031 scopus 로고    scopus 로고
    • Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease
    • Zidan J, Dashkovsky I, Stayerman C, Basher W, Cozacov C, Hadary A. Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease. Br J Cancer. 2005;93:552-6.
    • (2005) Br J Cancer. , vol.93 , pp. 552-556
    • Zidan, J.1    Dashkovsky, I.2    Stayerman, C.3    Basher, W.4    Cozacov, C.5    Hadary, A.6
  • 54
    • 84907855592 scopus 로고    scopus 로고
    • Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
    • de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science. 2014;346:251-6.
    • (2014) Science. , vol.346 , pp. 251-256
    • Bruin, E.C.1    McGranahan, N.2    Mitter, R.3    Salm, M.4    Wedge, D.C.5    Yates, L.6
  • 55
    • 84907808265 scopus 로고    scopus 로고
    • Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
    • Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science. 2014;346:256-9.
    • (2014) Science. , vol.346 , pp. 256-259
    • Zhang, J.1    Fujimoto, J.2    Zhang, J.3    Wedge, D.C.4    Song, X.5    Zhang, J.6
  • 58
    • 0026072872 scopus 로고
    • Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up
    • Elston CW, Ellis IO. Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-10.
    • (1991) Histopathology. , vol.19 , pp. 403-410
    • Elston, C.W.1    Ellis, I.O.2
  • 59
    • 84859637667 scopus 로고    scopus 로고
    • Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection
    • Hernandez L, Wilkerson PM, Lambros MB, Campion-Flora A, Rodrigues DN, Gauthier A, et al. Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection. J Pathol. 2012;227:42-52.
    • (2012) J Pathol. , vol.227 , pp. 42-52
    • Hernandez, L.1    Wilkerson, P.M.2    Lambros, M.B.3    Campion-Flora, A.4    Rodrigues, D.N.5    Gauthier, A.6
  • 60
    • 45349086985 scopus 로고    scopus 로고
    • Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia-a comparative study of four differently designed, high resolution microarray platforms
    • Gunnarsson R, Staaf J, Jansson M, Ottesen AM, Goransson H, Liljedahl U, et al. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia-a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer. 2008;47:697-711.
    • (2008) Genes Chromosomes Cancer. , vol.47 , pp. 697-711
    • Gunnarsson, R.1    Staaf, J.2    Jansson, M.3    Ottesen, A.M.4    Goransson, H.5    Liljedahl, U.6
  • 62
    • 34447552512 scopus 로고    scopus 로고
    • Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research
    • Tan DS, Lambros MB, Natrajan R, Reis-Filho JS. Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research. Lab Invest. 2007;87:737-54.
    • (2007) Lab Invest. , vol.87 , pp. 737-754
    • Tan, D.S.1    Lambros, M.B.2    Natrajan, R.3    Reis-Filho, J.S.4
  • 63
    • 79960732694 scopus 로고    scopus 로고
    • PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs
    • Weigelt B, Warne PH, Downward J. PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs. Oncogene. 2011;30:3222-33.
    • (2011) Oncogene. , vol.30 , pp. 3222-3233
    • Weigelt, B.1    Warne, P.H.2    Downward, J.3
  • 64
    • 84939167481 scopus 로고    scopus 로고
    • HER2-heterogeneity. https://github.com/charlottekyng/HER2-heterogeneity.
    • HER2-heterogeneity
  • 65
    • 84907299790 scopus 로고    scopus 로고
    • cBioPortal. http://www.cbioportal.org/.
    • cBioPortal.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.